SeekingAlpha · Oct 2, 2026
HealthEquity: AI Cash Fears Create A 'Buy' Opportunity
HealthEquity stock remains a "Buy" given its durable HSA growth, margin gains, and buybacks. Here's what investors need to know about HQY.
HQ
NASDAQ · HQY
HealthEquity, Inc.
Healthcare · Medical - Healthcare Information Services
$96.60
Up+$3.53 (+3.79%)
Updated Oct 21, 2026, 1:09 PM
SID Score
4.6/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 8.42B
- P/E ratio
- 43.63
- Dividend yield
- 0.00%
- 52-week range
- $72.76 – $107.62
- Volume
- 560.28K
- Avg. volume
- 875.23K
Price performance · HQY
HQY price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 20, 2026
HQY closed at $96.60 after 21 trading sessions, up 5.29% for the selected period.
- Last close
- $96.60
- Period change
- +5.29%
- Period low
- $87.25
- Period high
- $96.60
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | $93.60 | $96.75 | $93.60 | $96.60 | 560.28K |
| Oct 19, 2026 | $91.53 | $93.24 | $90.91 | $93.07 | 532.93K |
| Oct 16, 2026 | $93.23 | $93.835 | $91.625 | $92.03 | 550.7K |
| Oct 15, 2026 | $90.75 | $92.90 | $89.79 | $92.51 | 735.48K |
| Oct 14, 2026 | $89.84 | $92.72 | $89.08 | $89.87 | 820.36K |
| Oct 13, 2026 | $92.43 | $92.725 | $89.92 | $90.19 | 858.15K |
| Oct 12, 2026 | $91.94 | $92.90 | $91.37 | $92.03 | 610.86K |
| Oct 9, 2026 | $92.98 | $93.96 | $92.02 | $92.61 | 555.91K |
| Oct 8, 2026 | $91.09 | $93.54 | $90.88 | $93.05 | 772.77K |
| Oct 7, 2026 | $91.05 | $92.98 | $91.00 | $91.90 | 893.04K |
| Oct 6, 2026 | $91.43 | $92.01 | $90.34 | $91.05 | 726.86K |
| Oct 5, 2026 | $90.38 | $92.38 | $89.6701 | $91.55 | 1.02M |
| Oct 2, 2026 | $89.83 | $91.02 | $88.67 | $90.04 | 834.51K |
| Oct 1, 2026 | $88.46 | $89.51 | $87.79 | $89.37 | 726.54K |
| Sep 30, 2026 | $87.19 | $89.115 | $86.36 | $88.46 | 908.85K |
| Sep 29, 2026 | $88.67 | $88.67 | $86.015 | $87.25 | 1.02M |
| Sep 28, 2026 | $88.25 | $89.5075 | $87.255 | $88.44 | 1.5M |
| Sep 25, 2026 | $88.51 | $89.255 | $87.27 | $88.25 | 1.28M |
| Sep 24, 2026 | $90.96 | $91.10 | $88.25 | $88.60 | 901.77K |
| Sep 23, 2026 | $91.35 | $92.02 | $90.20 | $90.39 | 900.06K |
| Sep 22, 2026 | $95.77 | $95.97 | $91.2814 | $91.75 | 1.22M |
Latest HQY news
The latest Smart Investors Daily articles mentioning HQY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
HQY research
Overview
Company profile and research snapshot.
Company profile
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $120.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 18, 2026 | Barclays | Overweight | — |
| Aug 31, 2026 | Deutsche Bank | Buy | — |
| Aug 28, 2026 | BTIG | Buy | — |
| Jul 24, 2026 | BTIG | Buy | — |
| Jun 3, 2026 | RBC Capital | Outperform | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 30, 2026
HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors
DRAPER, Utah, Sept. 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced that Noémie Heuland, Chief Financial Officer of Moody’s Corporation (NYSE: MCO), has been elected to its board of directors (the “Board”) effective Sept. 24, 2026. Heuland will also serve on the Audit and Risk Committee and Cybersecurit
Benzinga · Sep 18, 2026
Barclays Maintains Overweight on HealthEquity, Raises Price Target to $115
Barclays analyst Peter Warendorf maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $110 to $115.
Yahoo · Sep 4, 2026
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
